The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Large Volume Wearable Injectors Market Research Report 2025
Synopsis
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
The global Large Volume Wearable Injectors market was valued at US$ 1471 million in 2023 and is anticipated to reach US$ 11290 million by 2030, witnessing a CAGR of 33.4% during the forecast period 2024-2030.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Large Volume Wearable Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Wearable Injectors.
Report Scope
The Large Volume Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Volume Wearable Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Wearable Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Wearable Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
The global Large Volume Wearable Injectors market was valued at US$ 1471 million in 2023 and is anticipated to reach US$ 11290 million by 2030, witnessing a CAGR of 33.4% during the forecast period 2024-2030.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
This report aims to provide a comprehensive presentation of the global market for Large Volume Wearable Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Wearable Injectors.
Report Scope
The Large Volume Wearable Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Volume Wearable Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Wearable Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Wearable Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Large Volume Wearable Injectors Market Overview
1.1 Product Overview and Scope of Large Volume Wearable Injectors
1.2 Large Volume Wearable Injectors Segment by Type
1.2.1 Global Large Volume Wearable Injectors Market Value Comparison by Type (2024-2030)
1.2.2 Electronical Injectors
1.2.3 Mechanical Injectors
1.2.4 Others
1.3 Large Volume Wearable Injectors Segment by Application
1.3.1 Global Large Volume Wearable Injectors Market Value by Application: (2024-2030)
1.3.2 Cancer Treatment
1.3.3 Auto-immune Treatment
1.3.4 Blood Disorders Treatment
1.3.5 Others
1.4 Global Large Volume Wearable Injectors Market Size Estimates and Forecasts
1.4.1 Global Large Volume Wearable Injectors Revenue 2019-2030
1.4.2 Global Large Volume Wearable Injectors Sales 2019-2030
1.4.3 Global Large Volume Wearable Injectors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Large Volume Wearable Injectors Market Competition by Manufacturers
2.1 Global Large Volume Wearable Injectors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Large Volume Wearable Injectors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Large Volume Wearable Injectors Average Price by Manufacturers (2019-2024)
2.4 Global Large Volume Wearable Injectors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Large Volume Wearable Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Wearable Injectors, Product Type & Application
2.7 Large Volume Wearable Injectors Market Competitive Situation and Trends
2.7.1 Large Volume Wearable Injectors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Large Volume Wearable Injectors Players Market Share by Revenue
2.7.3 Global Large Volume Wearable Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Large Volume Wearable Injectors Retrospective Market Scenario by Region
3.1 Global Large Volume Wearable Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Large Volume Wearable Injectors Global Large Volume Wearable Injectors Sales by Region: 2019-2030
3.2.1 Global Large Volume Wearable Injectors Sales by Region: 2019-2024
3.2.2 Global Large Volume Wearable Injectors Sales by Region: 2025-2030
3.3 Global Large Volume Wearable Injectors Global Large Volume Wearable Injectors Revenue by Region: 2019-2030
3.3.1 Global Large Volume Wearable Injectors Revenue by Region: 2019-2024
3.3.2 Global Large Volume Wearable Injectors Revenue by Region: 2025-2030
3.4 North America Large Volume Wearable Injectors Market Facts & Figures by Country
3.4.1 North America Large Volume Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Large Volume Wearable Injectors Sales by Country (2019-2030)
3.4.3 North America Large Volume Wearable Injectors Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Large Volume Wearable Injectors Market Facts & Figures by Country
3.5.1 Europe Large Volume Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Large Volume Wearable Injectors Sales by Country (2019-2030)
3.5.3 Europe Large Volume Wearable Injectors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Wearable Injectors Market Facts & Figures by Country
3.6.1 Asia Pacific Large Volume Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Large Volume Wearable Injectors Sales by Country (2019-2030)
3.6.3 Asia Pacific Large Volume Wearable Injectors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Large Volume Wearable Injectors Market Facts & Figures by Country
3.7.1 Latin America Large Volume Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Large Volume Wearable Injectors Sales by Country (2019-2030)
3.7.3 Latin America Large Volume Wearable Injectors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Large Volume Wearable Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Wearable Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Large Volume Wearable Injectors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Large Volume Wearable Injectors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Wearable Injectors Sales by Type (2019-2030)
4.1.1 Global Large Volume Wearable Injectors Sales by Type (2019-2024)
4.1.2 Global Large Volume Wearable Injectors Sales by Type (2025-2030)
4.1.3 Global Large Volume Wearable Injectors Sales Market Share by Type (2019-2030)
4.2 Global Large Volume Wearable Injectors Revenue by Type (2019-2030)
4.2.1 Global Large Volume Wearable Injectors Revenue by Type (2019-2024)
4.2.2 Global Large Volume Wearable Injectors Revenue by Type (2025-2030)
4.2.3 Global Large Volume Wearable Injectors Revenue Market Share by Type (2019-2030)
4.3 Global Large Volume Wearable Injectors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Large Volume Wearable Injectors Sales by Application (2019-2030)
5.1.1 Global Large Volume Wearable Injectors Sales by Application (2019-2024)
5.1.2 Global Large Volume Wearable Injectors Sales by Application (2025-2030)
5.1.3 Global Large Volume Wearable Injectors Sales Market Share by Application (2019-2030)
5.2 Global Large Volume Wearable Injectors Revenue by Application (2019-2030)
5.2.1 Global Large Volume Wearable Injectors Revenue by Application (2019-2024)
5.2.2 Global Large Volume Wearable Injectors Revenue by Application (2025-2030)
5.2.3 Global Large Volume Wearable Injectors Revenue Market Share by Application (2019-2030)
5.3 Global Large Volume Wearable Injectors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 West Pharmaceuticals
6.1.1 West Pharmaceuticals Corporation Information
6.1.2 West Pharmaceuticals Description and Business Overview
6.1.3 West Pharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 West Pharmaceuticals Large Volume Wearable Injectors Product Portfolio
6.1.5 West Pharmaceuticals Recent Developments/Updates
6.2 Unilife Corporation
6.2.1 Unilife Corporation Corporation Information
6.2.2 Unilife Corporation Description and Business Overview
6.2.3 Unilife Corporation Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Unilife Corporation Large Volume Wearable Injectors Product Portfolio
6.2.5 Unilife Corporation Recent Developments/Updates
6.3 CeQur
6.3.1 CeQur Corporation Information
6.3.2 CeQur Description and Business Overview
6.3.3 CeQur Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CeQur Large Volume Wearable Injectors Product Portfolio
6.3.5 CeQur Recent Developments/Updates
6.4 Sensile Medical AG
6.4.1 Sensile Medical AG Corporation Information
6.4.2 Sensile Medical AG Description and Business Overview
6.4.3 Sensile Medical AG Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sensile Medical AG Large Volume Wearable Injectors Product Portfolio
6.4.5 Sensile Medical AG Recent Developments/Updates
6.5 BD Medical
6.5.1 BD Medical Corporation Information
6.5.2 BD Medical Description and Business Overview
6.5.3 BD Medical Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BD Medical Large Volume Wearable Injectors Product Portfolio
6.5.5 BD Medical Recent Developments/Updates
6.6 Enable Injections
6.6.1 Enable Injections Corporation Information
6.6.2 Enable Injections Description and Business Overview
6.6.3 Enable Injections Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Enable Injections Large Volume Wearable Injectors Product Portfolio
6.6.5 Enable Injections Recent Developments/Updates
6.7 Roche Laboratories
6.6.1 Roche Laboratories Corporation Information
6.6.2 Roche Laboratories Description and Business Overview
6.6.3 Roche Laboratories Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Laboratories Large Volume Wearable Injectors Product Portfolio
6.7.5 Roche Laboratories Recent Developments/Updates
6.8 scPharmaceuticals
6.8.1 scPharmaceuticals Corporation Information
6.8.2 scPharmaceuticals Description and Business Overview
6.8.3 scPharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 scPharmaceuticals Large Volume Wearable Injectors Product Portfolio
6.8.5 scPharmaceuticals Recent Developments/Updates
6.9 SteadyMed Therapeutics
6.9.1 SteadyMed Therapeutics Corporation Information
6.9.2 SteadyMed Therapeutics Description and Business Overview
6.9.3 SteadyMed Therapeutics Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SteadyMed Therapeutics Large Volume Wearable Injectors Product Portfolio
6.9.5 SteadyMed Therapeutics Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Johnson & Johnson Large Volume Wearable Injectors Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Wearable Injectors Industry Chain Analysis
7.2 Large Volume Wearable Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Wearable Injectors Production Mode & Process
7.4 Large Volume Wearable Injectors Sales and Marketing
7.4.1 Large Volume Wearable Injectors Sales Channels
7.4.2 Large Volume Wearable Injectors Distributors
7.5 Large Volume Wearable Injectors Customers
8 Large Volume Wearable Injectors Market Dynamics
8.1 Large Volume Wearable Injectors Industry Trends
8.2 Large Volume Wearable Injectors Market Drivers
8.3 Large Volume Wearable Injectors Market Challenges
8.4 Large Volume Wearable Injectors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
